Market Forecast Meningococcal Vaccines Market share is projected to be worth USD 6.80 billion by 2032, registering a CAGR of 7.3% during the forecast period 2023 – 2032. Market Synopsis Meningococcal meningitis is a bacterial infection caused by Neisseria meningitides. Disease incidence is high in West and Central Africa, where historically, serogroup A has been the most important cause...